Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report

Australas J Dermatol. 2023 Feb;64(1):e72-e75. doi: 10.1111/ajd.13943. Epub 2022 Nov 1.

Abstract

Porokeratosis encompass a group of acquired and familial, preneoplastic, keratinization disorders, clinically characterized by atrophic macules or patches with a peripheral keratotic rim, the cornoid lamella. Genetic background is recognized as crucial in its pathophysiology, while immunosuppression and ultraviolet radiation represent triggering factors. We report the case of a woman who developed disseminate superficial actinic porokeratosis following the intake of hydroxyurea for a polycythaemia vera. Clinical, dermoscopic and histopathology data are showed, and the role of drug as a second-hit mutation trigger is discussed.

Keywords: Porokeratosis; adverse effect; genetic analysis; hydroxyurea; squamous cells neoplasm mevalonate kinase deficiency.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Hydroxyurea / adverse effects
  • Keratosis, Actinic*
  • Porokeratosis* / chemically induced
  • Porokeratosis* / drug therapy
  • Porokeratosis* / pathology
  • Ultraviolet Rays

Substances

  • Hydroxyurea